IMMUNIC, INC. — Director's Dealing 2024

Jul 24, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2024-07-22

Reporting Person: Skerjanec Simona (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-07-22	Stock Option	$1.46	A	100000	Acquired	2034-07-22	Common Stock (100000)	Direct
2024-07-22	Stock Option	$1.46	A	50000	Acquired	2034-07-22	Common Stock (50000)	Direct

Footnotes

F1: In relation to Reporting Person's directorship appointment at Immunic, Inc., Reporting Person received an inducement grant of options to purchase up to 100,000 shares of Immunic, Inc.'s common stock, which vest monthly over three years, effective July 22, 2024.

F2: Additionally, in respect of such appointment, Reporting Person received from Immunic, Inc. a grant of options to purchase up to 50,000 shares of Immunic, Inc.'s common stock, which vest monthly over one year, effective July 22, 2024.